Dl-Phenylalanine

Dl-Phenylalanine

SCHEMBL3963405

CC(=O)Cl.NC(Cc1ccccc1)C(=O)O

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 6/20 0.85
PTGS1 P23219 2/20 0.85
ALPI P09923 1/20 0.85
PKM P14618 1/20 0.85
XIAP P98170 1/20 0.85
SLC1A3 P43003 2/20 0.61
SLC1A2 P43004 2/20 0.61
SLC1A1 P43005 2/20 0.61
SLC15A1 P46059 1/20 0.56
NOS3 P29474 2/20 0.55
NOS1 P29475 2/20 0.55
NOS2 P35228 2/20 0.55
CYP1A2 P05177 2/20 0.53
LTA4H P09960 1/20 0.53
CYP3A4 P08684 3/20 0.53
ALDH1A1 P00352 2/20 0.53
ALOX15 P16050 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
HIF1A Q16665 2/20 0.53
ABCB11 O95342 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylalanine SCHEMBL430397 1.00 SLC7A5 (0.85) SLC7A5PTGS1ALPIPKMXIAP
Phenylalanine SCHEMBL7420162 0.98 SLC7A5 (0.81) SLC7A5PTGS1ALPIPKMXIAP
Dl-Phenylalanine SCHEMBL9444188 0.94 SLC7A5 (0.88) SLC7A5PTGS1ALPIPKMXIAP
Phenylalanine SCHEMBL9444191 0.94 SLC7A5 (0.88) SLC7A5PTGS1ALPIPKMXIAP
Dl-Phenylalanine SCHEMBL28051816 0.94 SLC7A5 (0.88) SLC7A5PTGS1ALPIPKMXIAP
Phenylalanine SCHEMBL8998194 0.92 SLC7A5 (0.85) SLC7A5PTGS1ALPIPKMXIAP
Phenylalanine SCHEMBL27787917 0.92 SLC7A5 (0.85) SLC7A5PTGS1ALPIPKMXIAP
Dl-Phenylalanine SCHEMBL27787918 0.92 SLC7A5 (0.85) SLC7A5PTGS1ALPIPKMXIAP
Dl-Phenylalanine SCHEMBL28570385 0.92 SLC7A5 (0.92) SLC7A5PTGS1ALPIPKMXIAP
Phenylalanine SCHEMBL28570383 0.92 SLC7A5 (0.92) SLC7A5PTGS1ALPIPKMXIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190075806-A1 PROTEINASE B AND LACTASE SOLUTION USING ITS PROPERTIES AND METHOD FOR PRODUCING THE SAME GODO SHUSEI CO., LTD. (JP) 2019-03-14 US disclosed
EP-3431596-A1 PROTEASE B, AND LACTASE SOLUTION UTILIZING PROPERTIES THEREOF AND METHOD FOR MANUFACTURING SAME Godo Shusei Co., Ltd. (JP) 2019-01-23 EP disclosed
EP-2082754-A1 BONE DEFECT FILLER, RELEASE-CONTROLLED CARRIER, AND THEIR PRODUCTION METHODS The University of Tokyo (JP) 2009-07-29 EP disclosed
EP-2055268-A1 BONE MODEL, BONE FILLER AND PROCESS FOR PRODUCING BONE FILLER Next21 K.K. (JP) 2009-05-06 EP disclosed
EP-1985318-A1 PROCESS FOR PRODUCING BONE GRAFTING MATERIAL, BONE GRAFTING MATERIAL, THREE-DIMENSIONAL SUPPORT FOR CELL CULTURE, AND SEPARATION SUPPORT FOR CHROMATOGRAPHY The University of Tokyo (JP) 2008-10-29 EP disclosed
EP-1389624-A1 Phosphorous-containing cysteine and serine protease inhibitors CEPHALON, INC. (US) 2004-02-18 EP disclosed
EP-0871454-B1 PHOSPHOROUS-CONTAINING CYSTEINE AND SERINE PROTEASE INHIBITORS CEPHALON INC (US) 2003-11-12 EP disclosed
EP-0891421-A4 BIOACTIVE MATERIAL SUBSTRATE FOR ENHANCED CELLULAR ATTACHMENT AND FUNCTION UNIV PENNSYLVANIA (US) 2001-07-25 EP disclosed
EP-0786996-A4 CYSTEINE PROTEASE AND SERINE PROTEASE INHIBITORS CEPHALON INC (US) 1999-02-03 EP disclosed
EP-0891421-A1 BIOACTIVE MATERIAL SUBSTRATE FOR ENHANCED CELLULAR ATTACHMENT AND FUNCTION THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1999-01-20 EP disclosed
EP-0871454-A4 1998-11-25 EP disclosed
EP-0871454-A1 PHOSPHOROUS-CONTAINING CYSTEINE AND SERINE PROTEASE INHIBITORS CEPHALON, INC. (US) 1998-10-21 EP disclosed
WO-1997035000-A1 BIOACTIVE MATERIAL SUBSTRATE FOR ENHANCED CELLULAR ATTACHMENT AND FUNCTION THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1997-09-25 WO disclosed
US-5658906-A Cysteine protease and serine protease inhibitors CEPHALON, INC. (US) 1997-08-19 US disclosed
EP-0786996-A1 CYSTEINE PROTEASE AND SERINE PROTEASE INHIBITORS CEPHALON, INC. (US) 1997-08-06 EP disclosed
US-5639732-A FOR TREATING NERVOUS SYSTEM DISORDERS OR AS ANTIINFLAMMATORY AGENT CEPHALON, INC. (US) 1997-06-17 US disclosed
WO-1997003679-A1 PHOSPHOROUS-CONTAINING CYSTEINE AND SERINE PROTEASE INHIBITORS CEPHALON, INC. (US) 1997-02-06 WO disclosed
WO-1996014067-A1 CYSTEINE PROTEASE AND SERINE PROTEASE INHIBITORS CEPHALON, INC. (US) 1996-05-17 WO disclosed
US-5498616-A IMIDAZOLE AND TRIAZOLE DERIVATIVES CEPHALON, INC. (US) 1996-03-12 US disclosed